anemia, nonspherocytic hemolytic G6PD deficiency anemia, nonspherocytic hemolytic, due to G6PD deficiency https://github.com/monarch-initiative/mondo/issues/4202 https://github.com/monarch-initiative/mondo/issues/4521 https://github.com/monarch-initiative/mondo/issues/4985 https://github.com/monarch-initiative/mondo/issues/6252 https://github.com/monarch-initiative/mondo/issues/8665 Any nonspherocytic hemolytic anemia in which the cause of the disease is a variation in the G6PD gene resulting in severely decreased activity levels of the enzyme glucose-6-phosphate dehydrogenase. Individuals with hemizygous or homozygous G6PD variants associated with chronic nonspherocytic hemolytic anemia (CNSHA) will clinically manifest CNSHA. Individuals with G6PD variants that cause CNSHA are at risk for severe neonatal jaundice and acute exacerbation of their chronic hemolytic anemia in response to certain medication exposures, chemical exposures, infections, or consumption of fava beans. GARD:0006520 MEDGEN:403555 hemolytic anemia due to G6PD deficiency UMLS:C2720289 severe hemolytic anaemia due to G6PD deficiency anemia, congenital, nonspherocytic hemolytic, 1, G6PD deficient MONDO:0010480 MESH:C567533 severe hemolytic anemia due to G6PD deficiency hemolytic anemia, G6PD deficient (favism), X-linked dominant anemia, nonspherocytic hemolytic, due to G6PD deficiency Class I G6PD deficiency Orphanet:466026 class I glucose-6-phosphate dehydrogenase deficiency DOID:0051003 OMIM:300908 hemolytic anaemia due to G6PD deficiency inborn disorder of pentose phosphate metabolism anemia due to erythrocyte enzyme disorder